We are testing a new subcutaneous treatment for individuals with extensive stage small cell lung cancer. The goal is to see how well it works compared to current options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Extensive Stage Small Cell Lung Cancer is a type of lung cancer that has spread beyond the lungs to other parts of the body, making it more challenging to treat. It is characterized by rapid growth and can lead to severe symptoms.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
